Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Intangibles (2016 - 2026)

Conmed filings provide 17 years of Intangibles readings, the most recent being $573.8 million for Q1 2026.

  • On a quarterly basis, Intangibles fell 5.91% to $573.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $573.8 million, a 5.91% decrease, with the full-year FY2025 number at $582.1 million, down 5.77% from a year prior.
  • Intangibles hit $573.8 million in Q1 2026 for Conmed, down from $582.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $689.5 million in Q3 2022 to a low of $463.4 million in Q1 2022.
  • Median Intangibles over the past 5 years was $625.6 million (2024), compared with a mean of $616.4 million.
  • Biggest five-year swings in Intangibles: decreased 6.17% in 2022 and later skyrocketed 45.34% in 2023.
  • Conmed's Intangibles stood at $681.8 million in 2022, then fell by 4.74% to $649.5 million in 2023, then fell by 4.9% to $617.7 million in 2024, then dropped by 5.77% to $582.1 million in 2025, then fell by 1.42% to $573.8 million in 2026.
  • The last three reported values for Intangibles were $573.8 million (Q1 2026), $582.1 million (Q4 2025), and $593.1 million (Q3 2025) per Business Quant data.